Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Government of the United States”

99 pharma patents match "The Government of the United States" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 99
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 99 pharmaceutical patents matching "The Government of the United States" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

99 results for “The Government of the United States” · 30,257 patents in full index Clear search

  1. US 10875907

    Filovirus antibody

    The Government of the United States, as represented by the Secretary of the Army · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  2. US 10865389

    DNA vaccines against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  3. US 10858634

    Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  4. US 10858633

    Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  5. US 10849970

    Antibody evolution immunogens

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  6. US 10828364

    Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  7. US 10829770

    Fusion proteins containing luciferase and a polypeptide of interest

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  8. US 10808225

    Use of PDL1 expressing cells to convert T cells into regulatory T cells

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  9. US 10793865

    Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial outer membrane extensions

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted

  10. US 10780185

    Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular membrane potential

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  11. US 10724007

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  12. US 10695414

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  13. US 10604548

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  14. US 10584355

    Chimpanzee adenoviral vector-based filovirus vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  15. US 10568956

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  16. US 10557118

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  17. US 10548946

    Therapeutic compositions for neutralizing type I interferons, and methods of use

    The Government of the United States, as represented by the Secretary of the Army · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  18. US 10525123

    Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  19. US 10513542

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  20. US 10507187

    Regenerative tissue grafts and methods of making same

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  21. US 10494435

    Human monoclonal antibodies specific for CD22

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  22. US 10471142

    Combination therapy using immunoglobulin and C1-Inhibitor

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  23. US 10449231

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  24. US 10443073

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.